Javascript must be enabled to continue!
Androgen and oestrogen concentrations in the ovary of the cyclic rat
View through CrossRef
In the 5-day cyclic rat the ovarian androgen and oestrogen concentrations, measured by radioimmunoassay, started a gradual rise on the day of metoestrus, reaching maximal values in the period from 22.00 h on dioestrus 2 until 17.00 h on the day of pro-oestrus. A steep decline in the ovarian androgen and oestrogen concentrations occurred between 17.00 and 21.00 h on the day of pro-oestrus.
Rats, injected intraperitoneally with an ovulation-blocking dose of pentobarbitone sodium (35 mg/kg body weight) at 13.00 h on the day of pro-oestrus, tended to show a decline in ovarian concentrations of androgens and oestrogens during late pro-oestrus, but this decrease was less steep than in saline-injected rats. At 10.00 and 14.00 h on the day after pro-oestrus the ovarian concentrations of androgens and oestrogens in rats treated with pentobarbitone sodium showed a further decline but values were still higher than those in saline-treated oestrous rats. At 17.00 h, i.e. 28 h after injection with pentobarbitone sodium, a distinct increase in the ovarian androgen and oestrogen concentrations was noted and a steep decline was observed at 21.00 h on the day after pro-oestrus.
Thus normal as well as delayed ovulation was preceded first by an increase and then by a steep decline in ovarian concentrations of oestrogens and androgens.
Title: Androgen and oestrogen concentrations in the ovary of the cyclic rat
Description:
In the 5-day cyclic rat the ovarian androgen and oestrogen concentrations, measured by radioimmunoassay, started a gradual rise on the day of metoestrus, reaching maximal values in the period from 22.
00 h on dioestrus 2 until 17.
00 h on the day of pro-oestrus.
A steep decline in the ovarian androgen and oestrogen concentrations occurred between 17.
00 and 21.
00 h on the day of pro-oestrus.
Rats, injected intraperitoneally with an ovulation-blocking dose of pentobarbitone sodium (35 mg/kg body weight) at 13.
00 h on the day of pro-oestrus, tended to show a decline in ovarian concentrations of androgens and oestrogens during late pro-oestrus, but this decrease was less steep than in saline-injected rats.
At 10.
00 and 14.
00 h on the day after pro-oestrus the ovarian concentrations of androgens and oestrogens in rats treated with pentobarbitone sodium showed a further decline but values were still higher than those in saline-treated oestrous rats.
At 17.
00 h, i.
e.
28 h after injection with pentobarbitone sodium, a distinct increase in the ovarian androgen and oestrogen concentrations was noted and a steep decline was observed at 21.
00 h on the day after pro-oestrus.
Thus normal as well as delayed ovulation was preceded first by an increase and then by a steep decline in ovarian concentrations of oestrogens and androgens.
Related Results
Correlation between urinary oestrogen levels determined by haemagglutination inhibition reaction and serum oestradiol levels determined by radioimmunoassay
Correlation between urinary oestrogen levels determined by haemagglutination inhibition reaction and serum oestradiol levels determined by radioimmunoassay
Abstract. Measurement of urinary or blood oestrogen is essential for a precise monitoring of follicular development in gonadotrophin therapy. Blood oestradiol levels are considered...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
Protein kinase activities in rat pancreatic islets of Langerhans
Protein kinase activities in rat pancreatic islets of Langerhans
1. Protein kinase activities in homogenates of rat islets of Langerhans were studied. 2. On incubation of homogenates with [gamma-32P]ATP, incorporation of 32P into protein occurre...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract
Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater, respectively...
Abstract PR04: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract PR04: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract
Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater, respectively...
Endocrine treatment of breast cancer
Endocrine treatment of breast cancer
Abstract
Endocrine manipulation has been recognized as a treatment modality for breast cancer for over 100 years. Oestrogen is an important promoter in the pathogene...
Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
AIM--To validate the use of a new mouse monoclonal antibody (1D5) directed against the N-terminal domain (A/B region) of the oestrogen receptor in an immunohistochemical assay (ER-...

